Genicular Artery Embolization - Non-Surgical Treatment for Knee Osteoarthritis

Genicular artery embolization (GAE) at YOUNIFY Clinic in Thailand is a minimally invasive, image-guided treatment designed to reduce persistent knee pain caused by osteoarthritis without the need for open surgery, joint replacement, or a permanent implant. The procedure uses a tiny catheter inserted through a small skin puncture to identify and selectively treat abnormal blood vessels around the knee associated with chronic inflammation and pain. Because there is no large surgical incision and no implant placed inside the joint, GAE offers a joint-preserving treatment option for selected patients who continue to experience significant symptoms despite conventional non-surgical treatment. Knee osteoarthritis is not simply a condition of cartilage wear. In many symptomatic patients, chronic inflammation of the joint lining is accompanied by the development of abnormal small blood vessels, known as pathological neovascularization, around the knee. These vessels can be closely associated with inflammatory activity and pain-producing nerve pathways. GAE is based on the principle that reducing blood flow through selected abnormal genicular arteries may help decrease this inflammatory environment and subsequently reduce pain. Current medical literature describes GAE as a promising minimally invasive vascular treatment for symptomatic knee osteoarthritis, although research is still evolving and outcomes can vary between patients. The treatment is performed under image guidance by an appropriately trained physician, enabling high-precision identification of the treated blood vessels. Access is gained through a tiny puncture in the skin, typically the size of a needle or just a few millimeters, rather than through a conventional surgical incision. A very small catheter is then guided through the blood vessels toward the arteries supplying the affected area of the knee. Contrast imaging is used to map the vascular anatomy and identify abnormal vessels associated with the osteoarthritic inflammatory process. Once the target vessels are confirmed, an embolic material is delivered through the catheter to selectively reduce their abnormal blood flow while preserving the circulation required by healthy tissues. The procedure does not remove damaged cartilage, reconstruct the joint, or replace the knee. Its purpose is to address an important inflammatory and vascular component of osteoarthritis-related pain. This makes it particularly relevant for patients who want to explore a minimally invasive treatment before proceeding to major orthopedic surgery. It may also be considered for patients whose symptoms remain troublesome despite standard conservative measures such as pain medication, anti-inflammatory medication, physical therapy, activity modification, or injections. Published reviews have generally reported improvements in pain and functional scores following GAE, with many studies showing meaningful symptom improvement during follow-up. The intervention may be particularly suitable for adults with symptomatic knee osteoarthritis who continue to have significant pain or reduced mobility despite non-surgical treatment. Patients may experience difficulty walking, standing for prolonged periods, climbing stairs, exercising, or performing everyday activities because of knee pain. GAE can also be considered when a patient seeks to delay or avoid knee replacement, provided the overall clinical assessment indicates the patient is an appropriate candidate. The decision should be based on the severity and pattern of osteoarthritis, the source of the patient's pain, previous treatments, medical history, imaging findings, vascular anatomy, and an assessment of whether the symptoms are likely to respond to a vascular intervention. Before treatment, the medical team will evaluate the knee and review the patient's symptoms, previous treatment history, medications, medical conditions, and available imaging. Diagnostic assessment may include physical examination and review or completion of X-ray or other appropriate imaging studies to confirm the diagnosis and determine the degree and distribution of osteoarthritis. The physician will also assess factors that may affect the safety or suitability of angiographic treatment, including vascular conditions, bleeding risk, medication use, allergies to contrast agents, kidney function, and other relevant medical considerations. This pre-procedure evaluation is important because GAE is not appropriate for every patient with knee osteoarthritis. On the day of treatment, the patient is prepared for the procedure and positioned for image-guided vascular access. Local anesthesia is used at the access site, and sedation may be provided when clinically appropriate. A small catheter is introduced through the skin and advanced through the arterial system toward the arteries supplying the knee. Using fluoroscopic or other appropriate imaging guidance, the interventional physician identifies the target genicular branches and performs detailed angiography to distinguish abnormal vascularity from normal blood supply. The embolization is then performed selectively to reduce pathological blood flow while minimizing the risk of affecting surrounding healthy tissues. Because GAE is performed through a small vascular access point rather than through a surgical incision, recovery is generally much shorter than recovery after knee replacement or other major knee surgery. According to the treatment information provided by YOUNIFY Clinic, most patients can return home on the same day and experience minimal downtime. Some patients may be able to walk on the day of treatment, although the exact timing of walking and return to normal activity depends on the individual procedure, access site, medical condition, and physician recommendations. The small puncture site may require temporary monitoring, and patients are generally advised to follow specific instructions regarding activity, wound care, medications, and follow-up. Pain relief after GAE does not necessarily occur immediately in every patient. The biological response develops as the treated vascular network and inflammatory process change over time. Some patients report improvement relatively early, while others experience a more gradual reduction in pain and improvement in mobility over the following weeks. Clinical studies have reported meaningful improvements in pain and osteoarthritis-related functional measures at follow-up periods ranging from 1 to 12 months. However, the degree and duration of benefit differ between individuals, and GAE should not be presented as a guaranteed cure for osteoarthritis. The potential duration of symptom relief can vary considerably. The information provided for this program indicates that results may last for several years in some patients, typically 1 to 5 years, depending on the individual. The actual duration of benefit cannot be reliably predicted for a specific patient because osteoarthritis is a chronic, progressive condition, and responses to GAE vary with disease severity, vascular anatomy, inflammation, activity level, and other clinical factors. Further treatment or other forms of osteoarthritis management may still be required in the future. An important advantage of GAE is that it is performed without replacing or mechanically altering the knee joint. Unlike knee arthroplasty, the embolization procedure involves no prosthetic implant and no bone removal. This can be attractive to patients who are not ready for joint replacement, want to postpone major surgery, or are looking for an intermediate treatment option between conservative management and orthopedic surgery. At the same time, GAE should not automatically be considered a substitute for knee replacement in every patient. Individuals with advanced structural joint destruction, severe deformity, mechanical symptoms, or other indications for arthroplasty may still require orthopedic surgical treatment, and the suitability of GAE should be determined on an individualized basis. The available medical evidence is encouraging but should be interpreted realistically. Recent systematic reviews and meta-analyses have found substantial improvements in pain and patient-reported function in many observational and prospective studies, with generally high technical success rates and mostly minor adverse events. A recent meta-analysis of 45 studies involving 2,205 patients reported clinically relevant improvements in pain and function, while noting that the overall certainty of evidence remained low to very low. Importantly, a separate study that placed greater emphasis on sham-controlled randomized trials found that these higher-quality trials had not yet demonstrated a statistically significant benefit over sham treatment, highlighting the need for larger and better-designed studies. GAE should therefore be regarded as an emerging treatment with promising clinical results rather than as an established replacement for standard osteoarthritis therapies. As with any medical procedure, GAE carries potential risks and side effects. These can include bruising or a hematoma at the vascular access site, temporary discomfort, transient skin discoloration, and other procedure-related vascular complications. Published evidence suggests that most reported adverse events are minor and self-limited, although uncommon or more serious complications can occur. The specific risk profile depends on the embolic material used, the patient's anatomy, the technique, and the treating team's experience. A recent systematic review reported transient skin discoloration and hematoma among the more frequently observed adverse events. GAE is therefore best understood as a targeted, minimally invasive option for carefully selected patients with symptomatic knee osteoarthritis. It is intended primarily to reduce pain and improve function by addressing abnormal vascularity and inflammation around the knee rather than correcting the underlying structural degeneration itself. The aim is to help patients move more comfortably, participate in daily activities, and potentially postpone the need for more invasive orthopedic surgery. At YOUNIFY Clinic in Thailand, the genicular artery embolization package is positioned as a non-surgical treatment for knee pain, offering a minimally invasive alternative between conventional conservative management and knee replacement. The combination of image-guided vascular treatment, minimal skin access, no implant, and short recovery makes GAE an appealing option for appropriately selected international patients seeking a joint-preserving approach to chronic osteoarthritis-related knee pain. A medical consultation and individual assessment are required before the procedure to determine whether GAE is appropriate. Treatment suitability depends on the patient's diagnosis, symptoms, imaging findings, previous treatments, overall health, vascular anatomy, and the physician's clinical judgment. GAE is not guaranteed to eliminate pain permanently and does not stop the underlying progression of osteoarthritis in every patient. Its role is to provide targeted symptom relief and improved function for selected patients while potentially allowing them to delay more invasive surgical treatment. The final treatment plan, expected benefits, risks, recovery recommendations, and follow-up schedule will be determined by the treating medical team at YOUNIFY Clinic based on the patient's individual condition.